Two New Techniques Make Genome Sequencing Faster and Cheaper
August 15th 2005Only a year after the National Human Genome Research Institute called for improving sequencing technology, two new methods were announced in the same week. What will the goal of a $1000 human genome mean for medicine and disease research?
Prescription Drug Addiction Study Recommends Marketing Sensitivity
July 18th 2005Prescription drug abuse nearly doubled over a three-year period, according to a new report. In addition to the statistics that you may have seen elsewhere, the study’s authors recommend ways to curb this trend including submitting all promotional material for controlled drugs to FDA.
Brazil Uses Compulsory Licensing Threat in Negotiations
July 18th 2005The possibility of Brazil compulsorily licensing Abbott Laboratory’s HIV/AIDS treatment Kaletra has re-awakened the debate how the World Trade Organization’s TRIPS agreement should be interpreted for the pharma industry. We asked experts to offer different viewpoints on this issue.
GSK Inks Deal with Non-Profit to Develop AIDS Vaccine
July 6th 2005The trend of public/private partnerships to combat diseases of the developing world continues with collaboration between GSK and the International AIDS Vaccine Initiative. We examine the details of the deal, the science GSK plans to use and the future of this trend.